BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 839737)

  • 21. Improvement of estradiol 17 beta-D-glucuronide cholestasis by intravenous administration of dimethylethanolamine in the rat.
    Alvaro D; Angelico M; Cantafora A; Gaudio E; Gandin C; Santini MT; Masella R; Capocaccia L
    Hepatology; 1991 Jun; 13(6):1158-72. PubMed ID: 1646761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between different bile salts in the biliary excretion of the rat.
    Kitani K; Kanai S
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):139-52. PubMed ID: 6844732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of complete biliary obstruction on bile secretion. Studies on the mechanisms of postcholestatic choleresis in the rat.
    Accatino L; Contreras A; Berdichevsky E; Quintana C
    J Lab Clin Med; 1981 Apr; 97(4):525-34. PubMed ID: 6259265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
    Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
    Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired localisation and transport function of canalicular Bsep in taurolithocholate induced cholestasis in the rat.
    Crocenzi FA; Mottino AD; Sánchez Pozzi EJ; Pellegrino JM; Rodríguez Garay EA; Milkiewicz P; Vore M; Coleman R; Roma MG
    Gut; 2003 Aug; 52(8):1170-7. PubMed ID: 12865277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of complete biliary obstruction on bile flow and bile acid excretion: postcholestatic choleresis in the rat.
    Accatino L; Contreras A; Fernańdez S; Quintana C
    J Lab Clin Med; 1979 May; 93(5):706-17. PubMed ID: 429869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taurohyocholate, taurocholate, and tauroursodeoxycholate but not tauroursocholate and taurodehydrocholate counteract effects of taurolithocholate in rat liver.
    Schölmerich J; Kitamura S; Baumgartner U; Miyai K; Gerok W
    Res Exp Med (Berl); 1990; 190(2):121-9. PubMed ID: 2349395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway.
    Baiocchi L; Tisone G; Russo MA; Longhi C; Palmieri G; Volpe A; Almerighi C; Telesca C; Carbone M; Toti L; De Leonardis F; Angelico M
    Transpl Int; 2008 Aug; 21(8):792-800. PubMed ID: 18435680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile canalicular membrane pathology in cytochalasin B-induced cholestasis.
    Oda M; Phillips MJ
    Lab Invest; 1977 Oct; 37(4):350-6. PubMed ID: 143551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic changes in the cytokeratin pericanalicular sheath in experimental cholestasis and alcoholic fatty liver.
    Ohta M; Marceau N; French SW
    Lab Invest; 1988 Jul; 59(1):60-74. PubMed ID: 2455832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary albumin excretion induced by bile salts in rats is a pathological phenomenon.
    Ohta M; Kitani K; Kanai S
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):373-88. PubMed ID: 2813958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver.
    Avner DL; Lee RG; Berenson MM
    J Clin Invest; 1981 Feb; 67(2):385-94. PubMed ID: 7462423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bile duct ligation on the ultrastructural morphology of hepatocytes.
    Vial JD; Simon FR; Mackinnon AM
    Gastroenterology; 1976 Jan; 70(1):85-92. PubMed ID: 1245288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport.
    Dumont M; Erlinger S; Uchman S
    Gastroenterology; 1980 Jul; 79(1):82-9. PubMed ID: 7380227
    [No Abstract]   [Full Text] [Related]  

  • 35. Cholestatic effect of large bilirubin loads and cholestasis protection conferred by cholic acid co-infusion: a molecular and ultrastructural study.
    Labori KJ; Arnkvaern K; Bjørnbeth BA; Press CM; Raeder MG
    Scand J Gastroenterol; 2002 May; 37(5):585-96. PubMed ID: 12059062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
    Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
    Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
    Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
    Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism and effect of 7-oxo-lithocholic acid 3-sulfate on bile flow and biliary lipid secretion in rats.
    Yamashita H; Setchell KD
    Hepatology; 1994 Sep; 20(3):663-71. PubMed ID: 8076924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choleric potencies of some bile acids and their effect on biliary excretion of eosin in the rat.
    Fischer E; Barth A; Klinger W; Gregus Z; Varga F
    Acta Biol Med Ger; 1980; 39(6):711-5. PubMed ID: 6161503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis.
    Monte MJ; Morales AI; Arevalo M; Alvaro I; Macias RI; Marin JJ
    Hepatology; 1996 May; 23(5):1208-17. PubMed ID: 8621155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.